PL429355A1 - Zastosowanie wodnego ekstraktu z raka pręgowatego - Google Patents

Zastosowanie wodnego ekstraktu z raka pręgowatego

Info

Publication number
PL429355A1
PL429355A1 PL429355A PL42935519A PL429355A1 PL 429355 A1 PL429355 A1 PL 429355A1 PL 429355 A PL429355 A PL 429355A PL 42935519 A PL42935519 A PL 42935519A PL 429355 A1 PL429355 A1 PL 429355A1
Authority
PL
Poland
Prior art keywords
extract
spinycheek
aplication
crayfish
aqueous extract
Prior art date
Application number
PL429355A
Other languages
English (en)
Other versions
PL237977B1 (pl
Inventor
Klara Zglińska
Tomasz Niemiec
Sławomir Jaworski
Adrian Czechowski
Andrzej Łozicki
Iwona Kosieradzka
Magdalena Matuszkiewicz
Piotr Koczoń
Original Assignee
Szkoła Główna Gospodarstwa Wiejskiego w Warszawie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Szkoła Główna Gospodarstwa Wiejskiego w Warszawie filed Critical Szkoła Główna Gospodarstwa Wiejskiego w Warszawie
Priority to PL429355A priority Critical patent/PL237977B1/pl
Publication of PL429355A1 publication Critical patent/PL429355A1/pl
Publication of PL237977B1 publication Critical patent/PL237977B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/82—Undefined extracts from animals from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Przedmiotem wynalazku jest zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego (Orconectes limosus), ewentualnie z dodatkiem nanocząstek złota, jako środka stymulującego wzrost komórek fibroblastów w hodowli in vitro. Zgodnie z wynalazkiem stosuje się wodny roztwór ekstraktu z raka pręgowatego zawierający liofilizowany ekstrakt w ilości od 100 mg do 1000 mg w 1 dm3 wody, do którego ewentualnie dodaje się koloid zawierający od 10 do 100 mg nanocząstek złota w 1 dm3 wody.
PL429355A 2019-03-21 2019-03-21 Zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego PL237977B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL429355A PL237977B1 (pl) 2019-03-21 2019-03-21 Zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL429355A PL237977B1 (pl) 2019-03-21 2019-03-21 Zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego

Publications (2)

Publication Number Publication Date
PL429355A1 true PL429355A1 (pl) 2020-10-05
PL237977B1 PL237977B1 (pl) 2021-06-14

Family

ID=72669293

Family Applications (1)

Application Number Title Priority Date Filing Date
PL429355A PL237977B1 (pl) 2019-03-21 2019-03-21 Zastosowanie liofilizowanego ekstraktu wodnego z całego raka pręgowatego

Country Status (1)

Country Link
PL (1) PL237977B1 (pl)

Also Published As

Publication number Publication date
PL237977B1 (pl) 2021-06-14

Similar Documents

Publication Publication Date Title
AR069788A1 (es) Formulacion de anticuerpo anti- cd20 humano y usos de la misma
MX2019007276A (es) Composiciones y métodos para mejora o aumento de la producción de ifn tipo i.
IN2015MU00865A (pl)
IN2012DN04940A (pl)
MX2011010673A (es) Formulaciones de nanoparticulas y usos de las mismas.
UY36542A (es) Formulaciones farmacéuticas para anticuerpos anti-tnf-alfa
MX2020007495A (es) Formulacion de adenovirus del grupo b.
MX2019007615A (es) Imagenología de celulas tumorales e inmunitarias basadas en expresion de pd-l1.
WO2018200481A8 (en) Methods of making improved human intestinal organoid compositions via application of strain and human intestinal organoid compositions thereof
BR112018015312A2 (pt) cepa fúngica isolada, cultura biologicamente pura, composição inoculante, kit, uso de uma cepa, e, método para aumentar quantidade/concentração de fosfato solúvel em um meio que contém fosfato insolúvel
MX2022004218A (es) Proteina de fusion multiespecifica y uso de la misma.
MX2022006882A (es) Formulaciones de anticuerpos anti-cd38 para administracion subcutanea.
IN2012DN05192A (pl)
MY189759A (en) Conjugate of finasteride with peptide
MX388073B (es) Composición farmacéutica, preparación y usos de la misma.
JP1811135S (ja) グラフィカルユーザーインターフェース
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
MX2016003238A (es) Composiciones antisepticas cationicas.
AU2017241626A1 (en) Viable cell compositions, and methods related to same
TWD202268S (zh) 連接器殼體
MX2024005649A (es) Proteinas quimericas basadas en sirp1a y cd40l.
EA201590032A1 (ru) Низкотоксичный загуститель и способы его применения
WO2019232474A3 (en) Compositions and methods for increasing consumption of water in companion animals
MX2021007643A (es) Composiciones para el cuidado bucal y metodos de uso.
EP4636054A3 (en) Narrow-emitting dyes, compositions comprising them, and processes for their manufacture and use